back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2018-05-15 Tx date 2018-03-26 |
$WNDR
The Wonderfilm Media Corporation (formerly, Westshire Capital II Corp.) |
Chiu, Szu Min (Jasmine)
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-150,000 vol |
50,000 | |
| Filed 2018-05-15 Tx date 2018-03-26 |
$WNDR
The Wonderfilm Media Corporation (formerly, Westshire Capital II Corp.) |
Chiu, Szu Min (Jasmine)
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
$-25,008.80
-62,522 vol $0.40 each |
20,841 | |
| Filed 2018-05-15 Tx date 2018-03-26 |
$WNDR
The Wonderfilm Media Corporation (formerly, Westshire Capital II Corp.) |
Chiu, Szu Min (Jasmine)
4 - Director of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$140,581
+281,162 vol $0.50 each |
331,162 | |
| Filed 2017-01-09 Tx date 2016-12-31 |
$LTY
Liberty Biopharma Inc. |
Chiu, Szu Min (Jasmine)
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,117,500 | ||
| Filed 2017-01-09 Tx date 2016-12-31 |
$LTY
Liberty Biopharma Inc. |
Chiu, Szu Min (Jasmine)
5 - Senior Officer of Issuer
Holder: Szu Min Chiu ITF Magnus Cheung (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
33,333 | ||
| Filed 2017-01-09 Tx date 2016-12-31 |
$LTY
Liberty Biopharma Inc. |
Chiu, Szu Min (Jasmine)
5 - Senior Officer of Issuer
Holder: Szu Min Chiu ITF Ayden Cheung (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
33,333 | ||
| Filed 2017-01-09 Tx date 2016-12-31 |
$LTY
Liberty Biopharma Inc. |
Chiu, Szu Min (Jasmine)
5 - Senior Officer of Issuer
Holder: Percy G.K. Cheung (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
108,900 | ||
| Filed 2016-10-24 Tx date 2016-10-17 |
$VVA
Avagenesis Corp. |
Chiu, Szu Min (Jasmine)
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$25,000
+100,000 vol $0.25 each |
400,000 | |
| Filed 2016-06-02 Tx date 2016-05-31 |
$
Westshire Capital II Corp. |
Chiu, Szu Min (Jasmine)
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
83,363 | ||
| Filed 2016-06-02 Tx date 2016-05-31 |
$
Westshire Capital II Corp. |
Chiu, Szu Min (Jasmine)
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
200,000 | ||
| Filed 2016-01-05 Tx date 2014-11-10 |
$VVS
Avapecia Life Sciences Corp. |
Chiu, Szu Min (Jasmine)
4 - Director of Issuer
Holder: Percy Gar Kay Cheung (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-01-05 Tx date 2015-12-21 |
$VVS
Avapecia Life Sciences Corp. |
Chiu, Szu Min (Jasmine)
4 - Director of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+652,500 vol |
2,152,500 | |
| Filed 2016-01-05 Tx date 2015-12-21 |
$VVS
Avapecia Life Sciences Corp. |
Chiu, Szu Min (Jasmine)
4 - Director of Issuer
Holder: Percy Gar Kay Cheung (Control or Direction)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+67,500 vol |
67,500 | |
| Filed 2015-07-17 Tx date 2014-11-10 |
$
Avapecia Life Sciences Corp. |
Chiu, Szu Min (Jasmine)
4 - Director of Issuer
Holder: Szu Min Chiu ITF Ayden Cheung (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2015-07-17 Tx date 2014-11-10 |
$
Avapecia Life Sciences Corp. |
Chiu, Szu Min (Jasmine)
4 - Director of Issuer
Holder: Szu Min Chiu ITF Magnus Cheung (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2015-07-17 Tx date 2014-11-10 |
$
Avapecia Life Sciences Corp. |
Chiu, Szu Min (Jasmine)
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,500,000 |